Narayan Kulkarni - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Narayan Kulkarni's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Narayan Kulkarni

Narayan Kulkarni

Verified

Associate Editor, BioSpectrum Asia

Bangalore

Final Covers

expat life.Previously covered: politics, travel, food national news, arts, history business, tech, beauty environment, world affairs, sports fashion, science,All things lifestyle: health

Doesn’t Cover

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 5

  • “Encephalitis is associated with significant costs to individuals and society, due to its high morbidity and mortality”

    By Narayan Kulkarni

    Mar. 31, 2025

  • Murata Vios plans to expand to Middle East, Europe & Japan

    By Narayan Kulkarni

    Apr. 26, 2023

  • “Encephalitis is associated with significant costs to individuals and society, due to its high morbidity and mortality”

    By Narayan Kulkarni

    Mar. 31, 2025

As seen in

Company Info

BioSpectrum Asia

BioSpectrum Asia is a prominent integrated B2B media platform focused on the healthcare and bioscience sectors in the Asia Pacific region. It serves as a vital information hub, providing news, analysis, and insights to professionals in pharmaceuticals, biotechnology, and related fields. The company utilizes print, digital, online, and event-based channels to engage its audience effectively. The platform publishes a monthly magazine and online content that covers innovations in biotech, pharma, and healthcare. It also organizes industry conferences and networking events to foster knowledge exchange and partnerships. BioSpectrum Asia offers specialized market intelligence, reporting on emerging trends such as green manufacturing practices and regional licensing agreements. Its content highlights collaborations with major pharmaceutical firms, biotech startups, and academic institutions, making it a key resource for industry stakeholders. The company emphasizes sustainability, regulatory compliance, and innovation in its reporting, addressing critical topics like clinical trials and healthcare policy.

Mumbai, , India

Founded: 2004